back to cluster viewer
cluster path 00111000111
45 words, 24,482 tokens
freq alpha suffix
Words in frequency order
1 | concentration | 24,387
|
2 | multimer | 16
|
3 | 3-o-β-d-glucoside | 6
|
4 | concentration/dose | 5
|
5 | cytokine-1 | 5
|
6 | lipidogram | 5
|
7 | a-200 | 4
|
8 | concentration-qt | 3
|
9 | fcgammar | 3
|
10 | hzd-9 | 3
|
11 | nitrogen/creatinine | 3
|
12 | time-cost | 3
|
13 | wave-length | 3
|
14 | ccid | 2
|
15 | leachabilities | 2
|
16 | reciprocals | 2
|
17 | trial-arm | 2
|
18 | -2/6 | 1
|
19 | 1.64+/-0.23 | 1
|
20 | 102-126 | 1
|
21 | 3-sulfate/4-sulfate | 1
|
22 | 6·88 | 1
|
23 | area-under-pvl | 1
|
24 | auc480h | 1
|
25 | cell/gland/bronchus | 1
|
26 | complex2 | 1
|
27 | concentraton | 1
|
28 | de-35 | 1
|
29 | digested/kg | 1
|
30 | esthers | 1
|
31 | form-dependent | 1
|
32 | increase.quetiapine | 1
|
33 | kappabalpha | 1
|
34 | level=465.332×10 | 1
|
35 | lyso-gl-3 | 1
|
36 | methylfluorescein | 1
|
37 | polypetide | 1
|
38 | protein-κ-bα | 1
|
39 | self-connection | 1
|
40 | serine-phosphorylation | 1
|
41 | synthase-deficient | 1
|
42 | therapeutic-free | 1
|
43 | tocotinine | 1
|
44 | was.02 | 1
|
45 | ≥14ng/l | 1
|
Words in alphabetical order
1 | -2/6 | 1
|
2 | 1.64+/-0.23 | 1
|
3 | 102-126 | 1
|
4 | 3-o-β-d-glucoside | 6
|
5 | 3-sulfate/4-sulfate | 1
|
6 | 6·88 | 1
|
7 | a-200 | 4
|
8 | area-under-pvl | 1
|
9 | auc480h | 1
|
10 | ccid | 2
|
11 | cell/gland/bronchus | 1
|
12 | complex2 | 1
|
13 | concentration | 24,387
|
14 | concentration-qt | 3
|
15 | concentration/dose | 5
|
16 | concentraton | 1
|
17 | cytokine-1 | 5
|
18 | de-35 | 1
|
19 | digested/kg | 1
|
20 | esthers | 1
|
21 | fcgammar | 3
|
22 | form-dependent | 1
|
23 | hzd-9 | 3
|
24 | increase.quetiapine | 1
|
25 | kappabalpha | 1
|
26 | leachabilities | 2
|
27 | level=465.332×10 | 1
|
28 | lipidogram | 5
|
29 | lyso-gl-3 | 1
|
30 | methylfluorescein | 1
|
31 | multimer | 16
|
32 | nitrogen/creatinine | 3
|
33 | polypetide | 1
|
34 | protein-κ-bα | 1
|
35 | reciprocals | 2
|
36 | self-connection | 1
|
37 | serine-phosphorylation | 1
|
38 | synthase-deficient | 1
|
39 | therapeutic-free | 1
|
40 | time-cost | 3
|
41 | tocotinine | 1
|
42 | trial-arm | 2
|
43 | was.02 | 1
|
44 | wave-length | 3
|
45 | ≥14ng/l | 1
|
Words in suffix order
1 | a-200 | 4
|
2 | level=465.332×10 | 1
|
3 | cytokine-1 | 5
|
4 | was.02 | 1
|
5 | complex2 | 1
|
6 | lyso-gl-3 | 1
|
7 | 1.64+/-0.23 | 1
|
8 | de-35 | 1
|
9 | -2/6 | 1
|
10 | 102-126 | 1
|
11 | 6·88 | 1
|
12 | hzd-9 | 3
|
13 | kappabalpha | 1
|
14 | ccid | 2
|
15 | 3-o-β-d-glucoside | 6
|
16 | polypetide | 1
|
17 | therapeutic-free | 1
|
18 | nitrogen/creatinine | 3
|
19 | tocotinine | 1
|
20 | increase.quetiapine | 1
|
21 | concentration/dose | 5
|
22 | 3-sulfate/4-sulfate | 1
|
23 | digested/kg | 1
|
24 | auc480h | 1
|
25 | wave-length | 3
|
26 | ≥14ng/l | 1
|
27 | area-under-pvl | 1
|
28 | lipidogram | 5
|
29 | trial-arm | 2
|
30 | methylfluorescein | 1
|
31 | serine-phosphorylation | 1
|
32 | concentration | 24,387
|
33 | self-connection | 1
|
34 | concentraton | 1
|
35 | fcgammar | 3
|
36 | multimer | 16
|
37 | leachabilities | 2
|
38 | reciprocals | 2
|
39 | esthers | 1
|
40 | cell/gland/bronchus | 1
|
41 | form-dependent | 1
|
42 | synthase-deficient | 1
|
43 | concentration-qt | 3
|
44 | time-cost | 3
|
45 | protein-κ-bα | 1
|